As of 2026-09-23, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -1.21 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 CAD, the upside of Biovaxys Technology Corp is -1,826.81%.
Based on its market price of 0.07 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 1,826.81%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.21 - -1.21 | -1.21 | -1,826.81% |
| P/E | (0.01) - (0.01) | (0.01) | -117.3% |
| DDM - Stable | (3.40) - (41.94) | (22.67) | -32483.0% |
| DDM - Multi | (2.20) - (21.23) | (4.00) | -5810.4% |
| Market Cap (mil) | 1.75 |
| Beta | 2.22 |
| Outstanding shares (mil) | 24.99 |
| Enterprise Value (mil) | 1.88 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.75% |
| Cost of Debt | 5.00% |
| WACC | 6.64% |